palladium has been researched along with Impotence in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, S; Bae, HJ; DeWeese, TL; Greco, S; Habtu, T; Huang, P; Lakshminarayanan, P; McNutt, T; Mian, OY; Narang, A; Peng, LC; Robertson, S; Song, DY; Tran, P | 1 |
| Inciūra, A; Jarusevicus, L; Juozaityte, E; Vaiciūnas, K | 1 |
| Burri, RJ; Stock, RG; Stone, NN; Unger, P | 1 |
| Buckstein, M; Snyder, KM; Stock, RG; Stone, NN | 1 |
| Buckstein, M; Campbell, C; Cesaretti, J; De Ruysscher, D; Hixson, R; Kerns, SL; Lammering, G; Ostrer, H; Rath, L; Rosenstein, BS; Shao, Y; Stock, R; Stone, N; Terk, M | 1 |
| Bissonette, EA; Chen, C; Theodorescu, D; Valicenti, RK | 1 |
| Büchler, F; Hawliczek, R; Madersbacher, S; Maier, U; Oismüller, R; Ponholzer, A; Rauchenwald, M; Somay, C | 1 |
| Atencio, DP; Burri, RJ; Cesaretti, JA; Peters, CA; Peters, SA; Rosenstein, BS; Stock, RG; Stone, NN | 1 |
| DeWyngaert, JK; Lavagnini, P; Stock, RG; Stone, NN; Unger, PD | 1 |
| Cash, JC; Dattoli, MJ | 1 |
| Zietman, A | 1 |
| Butler, WM; Donzella, JG; Dorsey, AT; Lief, JH; Merrick, GS | 1 |
| Benson, ML; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, K | 1 |
| Butler, WM; Lief, JH; Merrick, GS; Sutlief, S; Wallner, K | 1 |
| Abel, LJ; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Stipetich, RL | 1 |
| Anderson, RL; Butler, WM; Galbreath, RW; Kurko, BS; Lief, JH; Merrick, GS; Wallner, K | 1 |
2 review(s) available for palladium and Impotence
| Article | Year |
|---|---|
[Review on the effectiveness of prostate cancer brachytherapy].
Topics: Aged; Aged, 80 and over; Brachytherapy; Cohort Studies; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Palladium; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Ultrasonography; Urinary Retention | 2009 |
Management of patients receiving transperineal palladium-103 prostate implants.
Topics: Brachytherapy; Erectile Dysfunction; Humans; Male; Palladium; Perioperative Care; Prostatic Neoplasms; Radioisotopes | 1997 |
3 trial(s) available for palladium and Impotence
| Article | Year |
|---|---|
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
Topics: Age Factors; Aged; Brachytherapy; Erectile Dysfunction; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Polymorphism, Single Nucleotide; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal | 2013 |
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Biopsy; Brachytherapy; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Treatment Outcome; Ultrasonography; Urination Disorders | 1996 |
Short-term sexual function after prostate brachytherapy.
Topics: Aged; Brachytherapy; Dose-Response Relationship, Radiation; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Surveys and Questionnaires; Time Factors | 2001 |
11 other study(ies) available for palladium and Impotence
| Article | Year |
|---|---|
Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
Topics: Aged; Brachytherapy; Dose-Response Relationship, Radiation; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Organs at Risk; Palladium; Patient Reported Outcome Measures; Penile Erection; Prognosis; Prospective Studies; Prostate; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Spatio-Temporal Analysis; Time Factors | 2020 |
Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.
Topics: Aged; Analysis of Variance; Brachytherapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Middle Aged; Palladium; Pelvis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Salvage Therapy; Treatment Outcome; Urination Disorders | 2010 |
Long-term potency preservation following brachytherapy for prostate cancer.
Topics: Adult; Age Factors; Aged; Androgen Antagonists; Antineoplastic Agents; Brachytherapy; Combined Modality Therapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Palladium; Penile Erection; Phosphodiesterase Inhibitors; Prospective Studies; Prostatic Neoplasms; Radioisotopes | 2012 |
Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy.
Topics: Aged; Brachytherapy; Erectile Dysfunction; Humans; Longitudinal Studies; Male; Middle Aged; Palladium; Patient Satisfaction; Penile Erection; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal | 2002 |
The effect on erectile function of 103palladium implantation for localized prostate cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Erectile Dysfunction; Humans; Male; Middle Aged; Multivariate Analysis; Palladium; Prospective Studies; Prostatic Neoplasms; Radioisotopes | 2005 |
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
Topics: Aged; Analysis of Variance; Ataxia Telangiectasia Mutated Proteins; Brachytherapy; Cell Cycle Proteins; DNA-Binding Proteins; Dose-Response Relationship, Radiation; Erectile Dysfunction; Gastrointestinal Hemorrhage; Humans; Iodine Radioisotopes; Male; Middle Aged; Mutation, Missense; Palladium; Proctitis; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Radioisotopes; Rectal Diseases; Rectum; Tumor Suppressor Proteins | 2007 |
Radioactive seeds for prostate cancer.
Topics: Brachytherapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Palladium; Prostatic Neoplasms; Radioisotopes; Urinary Incontinence | 1998 |
A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
Topics: Age Factors; Brachytherapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neurons; Palladium; Phosphodiesterase Inhibitors; Piperazines; Prostate; Prostatic Neoplasms; Purines; Radioisotopes; Radiotherapy Dosage; Regression Analysis; Sildenafil Citrate; Sulfones | 2000 |
A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
Topics: Adenocarcinoma; Aged; Brachytherapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Penis; Phosphodiesterase Inhibitors; Piperazines; Prostatic Neoplasms; Purines; Radiation Dosage; Radioisotopes; Retrospective Studies; Sildenafil Citrate; Sulfones | 2001 |
Erectile function after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Brachytherapy; Coitus; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Penile Erection; Prostatic Neoplasms; Radioisotopes; Surveys and Questionnaires | 2002 |
Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity.
Topics: Adenocarcinoma; Aged; Brachytherapy; Erectile Dysfunction; Health Status; Humans; Iodine Radioisotopes; Male; Middle Aged; Obesity; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiometry; Treatment Outcome; Urologic Diseases | 2002 |